The microtubule-affecting drug paclitaxel has antiangiogenic activity.

557 indexed citations
published 1996

Countries where authors are citing The microtubule-affecting drug paclitaxel has antiangiogenic activity.

Specialization
Citations

This map shows the geographic impact of The microtubule-affecting drug paclitaxel has antiangiogenic activity.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by The microtubule-affecting drug paclitaxel has antiangiogenic activity. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites The microtubule-affecting drug paclitaxel has antiangiogenic activity. more than expected).

Fields of papers citing The microtubule-affecting drug paclitaxel has antiangiogenic activity.

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of The microtubule-affecting drug paclitaxel has antiangiogenic activity.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the The microtubule-affecting drug paclitaxel has antiangiogenic activity..

About The microtubule-affecting drug paclitaxel has antiangiogenic activity.

This paper, published in 1996, received 557 indexed citations . Written by Dorina Belotti, Veronica Vergani, Teresa Drudis, Patrizia Borsotti, G. Viale, Raffaella Giavazzi and Giulia Taraboletti covering the research area of Oncology, Molecular Biology and Cancer Research. It is primarily cited by scholars working on Oncology (285 citations), Molecular Biology (246 citations) and Cancer Research (151 citations). Published in PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/w78784878.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026